Michelle Lea
Chief Executive Officer at Oxford Immune Algorithmics
Michelle is an innovator at the forefront of disruptive technologies and AI.
She received an award for one of her innovations “OPRA” at the 2016 Patient Safety Awards for Technology & IT to Improve Patient Safety.
Michelle has vast and extensive corporate experience in medtech/ digital health/ Analytics/AI and has held executive board member positions these roles have seen her engage with executives and Stakeholders on a global basis.
She has also held many interim healthcare delivery roles within the NHS which include but not exhaustive of Turnaround Director and Director of Surgery. This led her to be nominated and win the 2019 IFAH top 100 influential healthcare leaders award in Las Vegas.
Michelle has a passion for innovation and is solution focused with a key emphasis on using data and tech to drive improvements. This combined with her business knowledge and global experience of both healthcare delivery and commercial is a powerful combination.
Visit website: https://www.immunealgorithmics.com/about/#michelle
See also: Oxford Immune Algorithmics (OIA) - Applying Artificial General Intelligence to deliver decentralised precision health and predictive medicine
Details last updated 08-Oct-2023
Michelle Lea is also referenced in the following:
Oxford Immune Algorithmics (OIA)
Applying Artificial General Intelligence to deliver decentralised precision health and predictive medicine